Aimovig * Pharmacy Only: Prescription
Company:
Novartis Ireland LimitedStatus:
No Recent UpdateLegal Category:
Product subject to medical prescription which may not be renewed (A)Active Ingredient(s):
This medicinal product is subject to additional monitoring.
*Additional information is available within the SPC or upon request to the company
When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.
Updated on 21 December 2021
File name
Aimovig-REGPIL PEN PF21-0324 Clean_Dec 2021_1640099319.pdf
Reasons for updating
- Change to section 5 - how to store or dispose
Updated on 21 December 2021
File name
Aimovig_REGSPC PF 21-0324 _Dec 2021_Clean_1640085794.pdf
Reasons for updating
- Change to section 6.3 - Shelf life
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 14 July 2021
File name
Aimovig_REG PIL_PF21-0118_06.05.2021_clean_Nürnberg _1626246997.pdf
Reasons for updating
- Change to section 5 - how to store or dispose
Updated on 23 June 2021
File name
Aimovig_REG SPC_PF21-0118_06.05.2021_clean_1624445990.pdf
Reasons for updating
- Change to section 4.8 - Undesirable effects
- Change to section 5.1 - Pharmacodynamic properties
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 03 September 2020
File name
Aimovig REGSPC PF 20-0014 Clean_August 2020_1599144674.pdf
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 03 September 2020
File name
Aimovig REGPIL PF 20-0014 Clean 08.2020_1599144592.pdf
Reasons for updating
- Change to section 2 - what you need to know - warnings and precautions
Updated on 20 February 2020
File name
Aimovig REGSPC PF 19-0192_Clean Feb 2020 medicines.ie_1582207616.pdf
Reasons for updating
- Change to Section 4.8 – Undesirable effects - how to report a side effect
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 18 February 2020
File name
Aimovig 70mg 140mg REGPIL PF19-0192 MT and IE Clean 02.2020 IPHA_1582030561.pdf
Reasons for updating
- Change to section 2 - what you need to know - warnings and precautions
Updated on 18 February 2020
File name
Aimovig REGSPC PF 19-0192_Clean Feb 2020_1582023772.pdf
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 5.1 - Pharmacodynamic properties
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 18 September 2019
File name
Aimovig clean Leaflet 70mg and 140mg IPHA_1568803160.pdf
Reasons for updating
- Correction of spelling/typing errors
Updated on 13 September 2019
File name
Aimovig_140mg-ml_70mg_REGSPC PF19-0186_August 2019_Clean updated_1568376159.pdf
Reasons for updating
- Change to section 5.1 - Pharmacodynamic properties
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 02 September 2019
File name
Aimovig_Clean_Leaflet 70mg and 140mg R89 August 2019 IPHA_1567428935.pdf
Reasons for updating
- Change to section 4 - possible side effects
Updated on 02 September 2019
File name
Aimovig_140mg-ml_70mg_REGSPC PF19-0186_August 2019_Clean_1567427858.pdf
Reasons for updating
- Change to section 4.8 - Undesirable effects
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 24 May 2019
File name
Aimovig_140mg-ml_70mg_Soln_In REGPIL_26-Apr-19_English_Clean_1558706177.pdf
Reasons for updating
- Introduction of new strength
Updated on 09 May 2019
File name
Aimovig_140mg-ml_70mg_Soln_Inj_REGSPC PF 19-0098_April 2019_Clean_1557398769.pdf
Reasons for updating
- Change to section 1 - Name of medicinal product
- Change to section 2 - Qualitative and quantitative composition
- Change to section 4.2 - Posology and method of administration
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.8 - Undesirable effects
- Change to section 5.1 - Pharmacodynamic properties
- Change to section 8 - Marketing authorisation number(s)
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 04 December 2018
File name
Aimovig 70mg SmPC updated 04.12.2018_1543942490.pdf
Reasons for updating
- Change to section 3 - Pharmaceutical form
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 05 November 2018
File name
Aimovig 70mg 1018970_R89_p1_LFT_X-4 RA approved 22.08.2018_1541418815.pdf
Reasons for updating
- New PIL for new product
Updated on 05 November 2018
File name
Aimovig 70mg SmPC_1541418748.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may not be renewed (A)